Universe Pharmaceuticals (UPC) Long-Term Investments: 2020-2024
- Universe Pharmaceuticals' Long-Term Investments rose 3.97% to $712,494 in Q3 2024 from the same period last year, while for Sep 2024 it was $712,494, marking a year-over-year increase of 3.97%. This contributed to the annual value of $712,494 for FY2024, which is 3.97% up from last year.
- According to the latest figures from Q3 2024, Universe Pharmaceuticals' Long-Term Investments is $712,494, which was up 2.89% from $692,492 recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Long-Term Investments ranged from a high of $735.0 billion in Q3 2020 and a low of $586,674 during Q1 2022.
- Over the past 3 years, Universe Pharmaceuticals' median Long-Term Investments value was $697,691 (recorded in 2022), while the average stood at $684,652.
- Its Long-Term Investments has fluctuated over the past 5 years, first tumbled by 100.00% in 2021, then increased by 24.10% in 2023.
- Quarterly analysis of 5 years shows Universe Pharmaceuticals' Long-Term Investments stood at $735.0 billion in 2020, then plummeted by 100.00% to $744,924 in 2021, then declined by 5.64% to $702,890 in 2022, then dropped by 2.50% to $685,307 in 2023, then climbed by 3.97% to $712,494 in 2024.
- Its Long-Term Investments was $712,494 in Q3 2024, compared to $692,492 in Q1 2024 and $685,307 in Q3 2023.
